TP53 and cancer: The KEGG analyses demonstrated that 102 common targets were enriched in signaling pathways, including the platinum drug resistance, p53 signaling pathway, proteoglycans in cancer, apoptosis, PI3K-Akt signaling pathway, TNF signaling pathway, and HIF-1 signaling pathway.